Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells.
W G Fang, … , C E Myers, J B Trepel
W G Fang, … , C E Myers, J B Trepel
Published January 1, 1992
Citation Information: J Clin Invest. 1992;89(1):191-196. https://doi.org/10.1172/JCI115562.
View: Text | PDF
Research Article Article has an altmetric score of 3

P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells.

  • Text
  • PDF
Abstract

To develop a new approach to the treatment of advanced, hormone-refractory prostate cancer, the signal transductions regulating the growth of human androgen-independent prostate carcinoma cell lines were studied. Agonist-stimulated Ca2+ mobilization, a critical regulatory event in other secretory cell types, was studied as a means of identifying previously undescribed plasma membrane receptors that may transduce a growth inhibitory signal. In all of the cell lines tested, P2-purinergic receptor agonists, including ATP and certain hydrolysis-resistant adenine nucleotides, induced a rapid, transient increase in cytoplasmic free Ca2+ that was detectable at 50 to 100 nM ATP, was maximal at 100 microM ATP, and was inhibited approximately 50% by chelation of extracellular Ca2+. Within 8 s after addition, ATP stimulated accumulation of the polyphosphatidylinositol products inositol (1, 4, 5) trisphosphate, inositol (1, 3, 4) trisphosphate, and inositol tetrakisphosphate. In addition to stimulating phosphatidylinositol turnover and Ca2+ mobilization, ATP and hydrolysis-resistant ATP analogues induced greater than 90% inhibition of the growth of all lines tested. These data demonstrate that human androgen-independent prostate carcinoma cells express functional P2-purinergic receptors linked to phospholipase C, and that agonists of this receptor are markedly growth inhibitory, suggesting a novel therapeutic approach to this common adult neoplasm.

Authors

W G Fang, F Pirnia, Y J Bang, C E Myers, J B Trepel

×

Total citations by year

Year: 2022 2021 2020 2019 2018 2017 2015 2014 2013 2012 2011 2010 2008 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 Total
Citations: 3 3 3 2 2 4 2 1 2 1 4 3 3 2 2 2 5 2 3 4 1 8 3 3 2 2 5 77
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (77)

Title and authors Publication Year
The P2 purinoceptors in prostate cancer.
Wang Z, Zhu S, Tan S, Zeng Y, Zeng H
Purinergic Signalling 2022
Extracellular ATP promotes breast cancer chemoresistance via HIF-1α signaling.
Yang H, Geng YH, Wang P, Zhang HQ, Fang WG, Tian XX
Cell Death and Disease 2022
ATP Promotes Oral Squamous Cell Carcinoma Cell Invasion and Migration by Activating the PI3K/AKT Pathway via the P2Y2-Src-EGFR Axis
Zhou Q, Liu S, Kou Y, Yang P, Liu H, Hasegawa T, Su R, Zhu G, Li M
ACS Omega 2022
P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer
J Maynard, J Lu, I Vidal, J Hicks, L Mummert, T Ali, R Kempski, A Carter, R Sosa, L Peiffer, C Joshu, T Lotan, A Marzo, K Sfanos
The Journal of Pathology 2021
Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents
S Ullah, MI El-Gamal, R El-Gamal, J Pelletier, J Sévigny, MK Shehata, HS Anbar, J Iqbal
European Journal of Medicinal Chemistry 2021
Autocrine and paracrine purinergic signaling in the most lethal types of cancer
M Reyna-Jeldes, M Díaz-Muñoz, JA Madariaga, C Coddou, FG Vázquez-Cuevas
Purinergic Signalling 2021
Extracellular ATP promotes breast cancer invasion and chemoresistance via SOX9 signaling
H Yang, YH Geng, P Wang, H Yang, YT Zhou, HQ Zhang, HY He, WG Fang, XX Tian
Oncogene 2020
Synthesis, biological evaluation, and docking studies of new pyrazole-based thiourea and sulfonamide derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase
S Ullah, MI El-Gamal, S Zaib, HS Anbar, SO Zaraei, RM Sbenati, J Pelletier, J Sévigny, CH Oh, J Iqbal
Bioorganic chemistry 2020
Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents
HS Anbar, R El-Gamal, S Ullah, SO Zaraei, M al-Rashida, S Zaib, J Pelletier, J Sévigny, J Iqbal, MI El-Gamal
Bioorganic chemistry 2020
Extracellular ATP promotes breast cancer invasion and epithelial‐mesenchymal transition via hypoxia‐inducible factor 2α signaling
H Yang, YH Geng, P Wang, YT Zhou, H Yang, YF Huo, HQ Zhang, Y Li, HY He, XX Tian, WG Fang
Cancer Science 2019
Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase
MI El-Gamal, S Ullah, SO Zaraei, S Jalil, S Zaib, DM Zaher, HA Omar, HS Anbar, J Pelletier, J Sévigny, J Iqbal
European Journal of Medicinal Chemistry 2019
Extracellular ATP drives breast cancer cell migration and metastasis via S100A4 production by cancer cells and fibroblasts
Y Liu, YH Geng, H Yang, H Yang, YT Zhou, HQ Zhang, XX Tian, WG Fang
Cancer Letters 2018
Screening pathogenic genes in oral squamous cell carcinoma based on the mRNA expression microarray data
Y Ding, P Liu, S Zhang, L Tao, J Han
International journal of molecular medicine 2018
Kca3.1 Activation Via P2y2 Purinergic Receptors Promotes Human Ovarian Cancer Cell (Skov-3) Migration
L Robles-Martínez, E Garay, MG Martel-Gallegos, A Cisneros-Mejorado, D Pérez-Montiel, A Lara, RO Arellano
Scientific Reports 2017
Molecular Oncology: Underlying Mechanisms and Translational Advancements
AA Farooqi, M Ismail
Molecular Oncology: Underlying Mechanisms and Translational Advancements 2017
Hyperthermia and associated changes in membrane fluidity potentiate P2X7 activation to promote tumor cell death
PA Mello, S Bian, LE Savio, H Zhang, J Zhang, W Junger, MR Wink, G Lenz, A Buffon, Y Wu, SC Robson
Oncotarget 2017
P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT-related genes Snail and E-cadherin
Y Qiu, Y Liu, WH Li, HQ Zhang, XX Tian, WG Fang
Oncology reports 2017
P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway
WH Li, Y Qiu, HQ Zhang, XX Tian, WG Fang, KX Chai
PloS one 2015
Radiated Ultrashort High-Power Electromagnetic Pulses Induce ATP Release in B16F10 Murine Melanoma Cells
S Macaire, A Catrain, S Tortel, JC Joly, S Girard, P Bonnet, A Vian
Journal of Electromagnetic Analysis and Applications 2015
P2X and P2Y Receptors—Role in the Pathophysiology of the Nervous System
K Puchałowicz, M Tarnowski, I Baranowska-Bosiacka, D Chlubek, V Dziedziejko
International journal of molecular sciences 2014
Purinergic signalling and cancer
G Burnstock, FD Virgilio
Purinergic Signalling 2013
P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells
WH Li, Y Qiu, HQ Zhang, Y Liu, JF You, XX Tian, WG Fang
British Journal of Cancer 2013
Purinergic signalling in the lower urinary tract
G Burnstock
Acta Physiologica 2012
Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate
L Feng, X Sun, E Csizmadia, L Han, S Bian, T Murakami, X Wang, SC Robson, Y Wu
Neoplasia (New York, N.Y.) 2011
Infection with Leishmania amazonensis upregulates purinergic receptor expression and induces host-cell susceptibility to UTP-mediated apoptosis
C Marques-da-Silva, MM Chaves, SP Chaves, VR Figliuolo, JR Meyer-Fernandes, S Corte-Real, C Lameu, H Ulrich, DM Ojcius, B Rossi-Bergmann, R Coutinho-Silva
Cellular Microbiology 2011
Therapeutic potential of purinergic signalling for diseases of the urinary tract
G Burnstock
BJU International 2011
Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and -independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3
M Aghaei, F Karami-Tehrani, M Panjehpour, S Salami, F Fallahian
The Prostate 2011
ATP sensitizes H460 lung carcinoma cells to cisplatin-induced apoptosis
EL Swennen, V Ummels, I Buss, U Jaehde, A Bast, PC Dagnelie
Chemico-Biological Interactions 2010
Extracellular ATP enhances in vitro invasion of prostate cancer cells by activating Rho GTPase and upregulating MMPs expression
Y Zhang, L Gong, H Zhang, Q Du, J You, X Tian, W Fang
Cancer Letters 2010
Current Topics in Membranes
TC Wagenknecht, Z Liu
Structure and Function of Calcium Release Channels 2010
Effect of extracellular ATP on the growth of hormone-refractory prostate cancer in vivo
M Shabbir, C Thompson, M Jarmulowiczc, D Mikhailidis, G Burnstock
BJU International 2008
Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer
M Shabbir, M Ryten, C Thompson, D Mikhailidis, G Burnstock
BJU International 2008
Purinergic receptor-mediated effects of adenosine 5′-triphosphate in urological malignant diseases
M Shabbir, G Burnstock
International Journal of Urology 2008
Mechanisms of adenosine-induced cytotoxicity and their clinical and physiological implications
SP Seetulsingh-Goorah
BioFactors 2006
Extracellular ATP induces apoptotic signaling in human monocyte leukemic cells, HL-60 and F-36P
MJ Yoon, HJ Lee, JH Kim, DK Kim
Archives of Pharmacal Research 2006
The metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells
F Cavaliere, V Nestola, S Amadio, N D'Ambrosi, DF Angelini, G Sancesario, G Bernardi, C Volonté
Neurobiology of Disease 2005
Feed Forward Cycle of Hypotonic Stress-induced ATP Release, Purinergic Receptor Activation, and Growth Stimulation of Prostate Cancer Cells
R Nandigama, M Padmasekar, M Wartenberg, H Sauer
The Journal of biological chemistry 2005
ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion
L Chen, H He, H Li, J Zheng, W Heng, J You, W Fang
Cancer Letters 2004
The role of intracellular pH in cell growth arrest induced by ATP
S Humez, M Monet, F Coppenolle, P Delcourt, N Prevarskaya
American journal of physiology. Cell physiology 2004
Extracellular ATP and adenosine induce cell apoptosis of human hepatoma Li-7A cells via the A3 adenosine receptor
LT Wen, AF Knowles
British Journal of Pharmacology 2003
Adenosine 5'-triphosphate (ATP) is an excitatory cotransmitter with noradrenaline to the smooth muscle of the rat prostate gland
S Ventura, RK Dewalagama, LC Lau
British Journal of Pharmacology 2003
Expression of Purinergic Receptors in Non-melanoma Skin Cancers and Their Functional Roles in A431 Cells
AV Greig, C Linge, V Healy, P Lim, E Clayton, MH Rustin, DA McGrouther, G Burnstock
Journal of Investigative Dermatology 2003
Randomized clinical trial of adenosine 5′-triphosphate on tumor growth and survival in advanced lung cancer patients:
HJ Agteresch, SA Burgers, A der Gaast, JH Wilson, PC Dagnelie
Anti-Cancer Drugs 2003
Growth inhibition of lung cancer cells by adenosine 5?-triphosphate
HJ Agteresch, MH van Rooijen, JW van den Berg, GJ Minderman-Voortman, JH Wilson, PC Dagnelie
Drug Development Research 2003
Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y(2)-receptors
K Maaser, M Höpfner, H Kap, AP Sutter, B Barthel, B Lampe, M Zeitz, H Scherübl
British Journal of Cancer 2002
Regulation of the expression of protein kinase C isoenzymes in rat ventral prostate: effects of age, castration and flutamide treatment
L Montalvo, M Sánchez-Chapado, JC Prieto, MJ Carmena
Life Sciences 2002
Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells
R Janssens, JM Boeynaems
British Journal of Pharmacology 2001
Purinergic and Pyrimidinergic Signalling II
MP Abbracchio, M Williams
2001
Activation of p90RSK and growth stimulation of multicellular tumor spheroids are dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP
H Sauer, B Klimm, J Hescheler, M Wartenberg
The FASEB Journal 2001
Adenosine- and Adenine-Nucleotide-Mediated Inhibition of Normal and Transformed Keratinocyte Proliferation is Dependent upon Dipyridamole-Sensitive Adenosine Transport
JR Brown, K Cornell, PW Cook
Journal of Investigative Dermatology 2000
Effects of adenine nucleosides and nucleotides on neuromuscular transmission to the prostatic stroma of the rat
A Preston, WA Lau, JN Pennefather, S Ventura
British Journal of Pharmacology 2000
Extracellular ATP-dependent suppression of proliferation and induction of differentiation of human HL-60 leukemia cells by distinct mechanisms
A Conigrave
Biochemical Pharmacology 2000
The purinergic calcium channels P2X1,2,5,7 are down-regulated while P2X3,4,6 are up-regulated during apoptosis in the ageing rat prostate
M Slater, J A Barden, C R Murphy
The Histochemical Journal 2000
Adenosine Triphosphate: Established and Potential Clinical Applications
HJ Agteresch, PC Dagnelie, JW van den Berg O., JH Paul
Drugs 1999
Growth Inhibition of HL-60 Cells by Extracellular ATP: Concentration-Dependent Involvement of a P2 Receptor and Adenosine Generation
SP Seetulsingh-Goorah, BW Stewart
Biochemical and Biophysical Research Communications 1998
Correlation of expression of bombesin-like peptides and receptors with growth inhibition by an anti-bombesin antibody in small-cell lung cancer cell lines1The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Navy or the Department of Defense. This is a US Government work. There are no restrictions on its use.1
HK Yang, FM Scott, JB Trepel, JF Battey, BE Johnson, MJ Kelley
Lung Cancer 1998
Expression of Functional P2-Purinergic Receptors in Primary Cultures of Human Colorectal Carcinoma Cells
M Höpfner, K Lemmer, A Jansen, C Hanski, EO Riecken, M Gavish, B Mann, H Buhr, G Glassmeier, H Scherübl
Biochemical and Biophysical Research Communications 1998
Principles of Medical Biology
JO Jørgensen
Principles of Medical Biology 1998
Nucleotide metabolizing ectoenzymes are upregulated in A431 cells periodically treated with cytostatic ATP leading to partial resistance without preventing apoptosis
H S Wiendl, C Schneider, A Ogilvie
Biochimica et Biophysica Acta 1998
Inhibition of the 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Pathway Induces p53-independent Transcriptional Regulation of p21 WAF1/CIP1 in Human Prostate Carcinoma Cells
SJ Lee, MJ Ha, J Lee, PM Nguyen, YH Choi, F Pirnia, WK Kang, XF Wang, SJ Kim, JB Trepel
The Journal of biological chemistry 1998
Purinergic Signalling: Pathophysiological Roles
MP Abbracchio, G Burnstock
The Japanese Journal of Pharmacology 1998
The P2 Nucleotide Receptors
JT Turner, GA Weisman, JS Fedan
1998
Calcium signaling in prostate cancer cells: Evidence for multiple receptors and enhanced sensitivity to bombesin/GRP
WJ Wasilenko, J Cooper, AJ Palad, KD Somers, PF Blackmore, JS Rhim, GL Wright, PF Schellhammer
The Prostate 1997
Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer
D Raghavan
European Journal of Cancer 1997
Ontogenic Development of the Adenylyl Cyclase Enzyme and the αs, αi1 and αi2 G-protein Regulatory Subunits from Rat Prostate
MG Juarranz, I Carrero, R Busto, MJ Carmena, JC Prieto, LG Guijarro
Cellular Signalling 1997
P1 and P2 receptors in cell growth and differentiation
MP Abbracchio
Drug Development Research 1996
Cystic fibrosis hetero–and homozygosity is associated with inhibition of breast cancer growth
EH Abraham, P Vos, J Kahn, SA Grubman, DM Jefferson, I Ding, P Okunieff
Nature Medicine 1996
Modulation of Cyclic AMP and Inositol Phosphate Production in Rat Prostatic Cultures by VIP/PACAP, ATP, and Carbachol: Role in Prostatic Proliferation
LG Guijarro, MG Juarranz, MJ Marinero, L Pajuelo, MJ Carmena, JC Prieto
Annals of the New York Academy of Sciences 1996
Effect of Intraperitoneal ATP on Tumor Growth and Bone Marrow Radiation Tolerance
J Froio, EH Abraham, R Soni, A Epstein, P Okunieff
Acta Oncologica 1995
Adenosine and Adenine Nucleotides Inhibit the Autonomous and Epidermal Growth Factor-Mediated Proliferation of Cultured Human Keratinocytes
PW Cook, NM Ashton, MR Pittelkow
Journal of Investigative Dermatology 1995
Neuronal responses to purinoceptor agonists in the leech central nervous system
KH Backus, S Braum, F Lohner, JW Deitmer
Journal of Neurobiology 1994
Utilization of ATP administration for the treatment of cancer and AIDS
E Rapaport
Expert Opinion on Investigational Drugs 1994
Tumor growth retardation and pathophysiological effects of adenosine 5′-triphosphate therapy measured by thallium washout,31P nuclear magnetic resonance, laser doppler flowmetry, and intradermal angiogenesis
P Okunieff, J Froio, R Soni, J Kahn, L Gerweck, R Zlotecki, EH Abraham
Radiation Oncology Investigations 1993
Growth inhibition of breast cancer cells induced by exogenous ATP
B Spungin, I Friedberg
Journal of Cellular Physiology 1993
Physiological and pathological roles of purines: An update
G Burnstock
Drug Development Research 1993
Anticancer activities of adenine nucleotides in tumor bearing hosts
E Rapaport
Drug Development Research 1993
Differential growth regulation of a metastatic human lung carcinoma cell line through activation of phosphatidyl inositol turnover signal transduction pathway
W Fang, B Wu
Clinical & Experimental Metastasis 1993

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 6 patents
18 readers on Mendeley
See more details